Cargando…
Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders
BACKGROUND: In 2004, patient advocate groups were major players in helping pass and implement significant public policy and funding initiatives in stem cells and regenerative medicine. In the following years, advocates were also actively engaged in Washington DC, encouraging policy makers to broaden...
Autores principales: | Matthews, Kirstin R. W., Iltis, Ana S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634187/ https://www.ncbi.nlm.nih.gov/pubmed/26537611 http://dx.doi.org/10.1186/s12910-015-0069-x |
Ejemplares similares
-
Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action
por: Caulfield, Timothy, et al.
Publicado: (2019) -
Endometrial Receptivity Analysis (ERA) test: an unproven
technology
por: Ben Rafael, Zion
Publicado: (2021) -
Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs
por: Amon, Joseph J
Publicado: (2008) -
Unproven stem cell interventions: A global public health problem requiring global deliberation
por: Master, Zubin, et al.
Publicado: (2021) -
NTD policy priorities: Science, values, and agenda setting
por: Iltis, Ana S., et al.
Publicado: (2017)